These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22115966)

  • 1. Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.
    Ma Y; Cheng Q; Ren Z; Xu L; Zhao Y; Sun J; Hu S; Xiao W
    Cancer Lett; 2012 Apr; 317(2):150-6. PubMed ID: 22115966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation.
    Lecosnier S; Cordier C; Simon P; François JC; Saison-Behmoaras TE
    FASEB J; 2011 Jul; 25(7):2201-10. PubMed ID: 21402719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preferential expression of IGF-1Ec (MGF) transcript in cancerous tissues of human prostate: evidence for a novel and autonomous growth factor activity of MGF E peptide in human prostate cancer cells.
    Armakolas A; Philippou A; Panteleakou Z; Nezos A; Sourla A; Petraki C; Koutsilieris M
    Prostate; 2010 Aug; 70(11):1233-42. PubMed ID: 20564425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Luteolin inhibits insulin-like growth factor 1 receptor signaling in prostate cancer cells.
    Fang J; Zhou Q; Shi XL; Jiang BH
    Carcinogenesis; 2007 Mar; 28(3):713-23. PubMed ID: 17065200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zyflamend reduces the expression of androgen receptor in a model of castrate-resistant prostate cancer.
    Huang EC; Chen G; Baek SJ; McEntee MF; Collier JJ; Minkin S; Biggerstaff J; Whelan J
    Nutr Cancer; 2011 Nov; 63(8):1287-96. PubMed ID: 21958043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bombesin regulates cyclin D1 expression through the early growth response protein Egr-1 in prostate cancer cells.
    Xiao D; Chinnappan D; Pestell R; Albanese C; Weber HC
    Cancer Res; 2005 Nov; 65(21):9934-42. PubMed ID: 16267018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-1 receptor acts as a growth regulator in synovial sarcoma.
    Friedrichs N; Küchler J; Endl E; Koch A; Czerwitzki J; Wurst P; Metzger D; Schulte JH; Holst MI; Heukamp LC; Larsson O; Tanaka S; Kawai A; Wardelmann E; Buettner R; Pietsch T; Hartmann W
    J Pathol; 2008 Dec; 216(4):428-39. PubMed ID: 18855347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin inhibits the proliferation of human prostate cancer PC-3 cells via down-regulation of the insulin-like growth factor 1 receptor.
    Sekine Y; Furuya Y; Nishii M; Koike H; Matsui H; Suzuki K
    Biochem Biophys Res Commun; 2008 Jul; 372(2):356-61. PubMed ID: 18489904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1.
    Chen A; Xu J; Johnson AC
    Oncogene; 2006 Jan; 25(2):278-87. PubMed ID: 16170359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HoxA9 induces insulin-like growth factor-1 receptor expression in B-lineage acute lymphoblastic leukemia.
    Whelan JT; Ludwig DL; Bertrand FE
    Leukemia; 2008 Jun; 22(6):1161-9. PubMed ID: 18337761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells.
    Bostedt KT; Schmid C; Ghirlanda-Keller C; Olie R; Winterhalter KH; Zapf J
    Exp Cell Res; 2001 Dec; 271(2):368-77. PubMed ID: 11716549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
    Furukawa J; Wraight CJ; Freier SM; Peralta E; Atley LM; Monia BP; Gleave ME; Cox ME
    Prostate; 2010 Feb; 70(2):206-18. PubMed ID: 19790231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Egr-1 mediates transcriptional activation of IGF-II gene in response to hypoxia.
    Bae SK; Bae MH; Ahn MY; Son MJ; Lee YM; Bae MK; Lee OH; Park BC; Kim KW
    Cancer Res; 1999 Dec; 59(23):5989-94. PubMed ID: 10606246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth factor/growth factor receptor loops in autocrine growth regulation of human prostate cancer DU145 cells.
    Ligęza J; Ligęza J; Klein A
    Acta Biochim Pol; 2011; 58(3):391-6. PubMed ID: 21887406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
    Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Schayek H; Bentov I; Rotem I; Pasmanik-Chor M; Ginsberg D; Plymate SR; Werner H
    Growth Horm IGF Res; 2010 Feb; 20(1):68-72. PubMed ID: 19703789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.